Catalyst Pharmaceuticals, Inc. (CPRX) SEC filings
CPRX SEC filings moved a median of -0.06% by the close. CPRX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CPRX overview →
75 measured CPRX SEC filing events.
Where these CPRX SEC filings landedvs 69 measured CPRX SEC filing reactions
| Middle 50% of CPRX SEC filing reactions | -1.69% to +0.81% |
|---|---|
| Median reaction (to close) | -0.06% |
| Measured reactions | 69 |
Point-in-time · zero look-ahead
Half of the 69 CPRX SEC filing events with a measured close landed between -1.69% and +0.81%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G CATALYST PHARMACEUTICALS | SEC filing · Form 15-12G | — | — | |
| Form EFFECT CATALYST PHARMACEUTICALS | SEC filing · Form EFFECT | — | — | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jul 15 | SEC filing · Form 8-K | — | — | |
| Form POS AM CATALYST PHARMACEUTICALS | SEC filing · Form POS | — | — | |
| Form POSASR CATALYST PHARMACEUTICALS | SEC filing · Form POSASR | — | — | |
| Form S-8 POS CATALYST PHARMACEUTICALS | SEC filing · Form S-8 | — | — | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jul 08 | SEC filing · Form 8-K | +0.02% | +0.00% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jun 30 | SEC filing · Form 8-K | -0.02% | -0.03% | |
| Form DEFA14A CATALYST PHARMACEUTICALS | SEC filing · Form DEFA14A | -0.02% | -0.03% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jun 22 | SEC filing · Form 8-K | +0.00% | +0.10% | |
| Form DEFM14A CATALYST PHARMACEUTICALS | SEC filing · Form DEFM14A | +0.13% | +0.13% | |
| Form PREM14A CATALYST PHARMACEUTICALS For: May 28 | SEC filing · Form PREM14A | +0.02% | -0.19% | |
| Form DEFA14A CATALYST PHARMACEUTICALS | SEC filing · Form DEFA14A | +0.00% | -0.06% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.06% | |
| Form 8-K CATALYST PHARMACEUTICALS For: May 11 | SEC filing · Form 8-K | +0.00% | -0.06% | |
| Form DEFA14A CATALYST PHARMACEUTICALS | SEC filing · Form DEFA14A | +0.08% | +0.00% | |
| Form 8-K CATALYST PHARMACEUTICALS For: May 06 | SEC filing · Form 8-K | -0.14% | +0.08% | |
| Form DEFA14A CATALYST PHARMACEUTICALS | SEC filing · Form DEFA14A | -0.14% | +0.08% | |
| Form 10-K/A CATALYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +0.85% | +2.13% | |
| Form 8-K/A CATALYST PHARMACEUTICALS For: Mar 18 | SEC filing · Form 8-K | -0.44% | -1.06% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Mar 18 | SEC filing · Form 8-K | -0.44% | -1.06% | |
| Form 10-K CATALYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -2.01% | +2.18% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Feb 25 | SEC filing · Form 8-K | -2.01% | +2.18% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jan 12 | SEC filing · Form 8-K | -1.85% | +2.56% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -1.03% | -7.04% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Nov 05 | SEC filing · Form 8-K | -1.03% | -7.04% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Oct 01 | SEC filing · Form 8-K | -1.79% | +0.68% | |
| Form 8-K/A CATALYST PHARMACEUTICALS For: Aug 25 | SEC filing · Form 8-K | -0.15% | +0.73% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Aug 25 | SEC filing · Form 8-K | +0.00% | -3.30% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Aug 06 | SEC filing · Form 8-K | +1.17% | +0.81% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -11.35% | -9.43% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Aug 06 | SEC filing · Form 8-K | -11.35% | -9.43% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Aug 01 | SEC filing · Form 8-K | +0.28% | +2.25% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jun 01 | SEC filing · Form 8-K | +0.12% | +0.44% | |
| Form 8-K CATALYST PHARMACEUTICALS For: May 20 | SEC filing · Form 8-K | -0.84% | -0.32% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -2.97% | +0.75% | |
| Form 8-K CATALYST PHARMACEUTICALS For: May 07 | SEC filing · Form 8-K | -2.97% | +0.75% | |
| Form ARS CATALYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | +0.40% | +2.33% | |
| Form DEF 14A CATALYST PHARMACEUTICALS For: May 20 | SEC filing · Form DEF | -0.76% | +1.42% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Apr 08 | SEC filing · Form 8-K | +1.38% | +8.75% | |
| Form 10-K CATALYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +4.57% | -2.96% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Feb 26 | SEC filing · Form 8-K | +4.57% | -2.96% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jan 17 | SEC filing · Form 8-K | +0.27% | +2.30% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jan 21 | SEC filing · Form 8-K | -0.87% | -0.22% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jan 13 | SEC filing · Form 8-K | -0.73% | +1.88% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jan 08 | SEC filing · Form 8-K | -1.53% | -4.07% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -2.06% | -3.96% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Nov 06 | SEC filing · Form 8-K | -2.06% | -3.96% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Sep 24 | SEC filing · Form 8-K | -0.35% | -0.84% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +0.17% | +4.57% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Aug 07 | SEC filing · Form 8-K | +0.17% | +4.57% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jul 24 | SEC filing · Form 8-K | -0.34% | -1.69% | |
| Form POS EX CATALYST PHARMACEUTICALS | SEC filing · Form POS | +0.25% | -0.55% | |
| Form S-8 CATALYST PHARMACEUTICALS | SEC filing · Form S-8 | +0.25% | -0.55% | |
| Form 8-K CATALYST PHARMACEUTICALS For: May 30 | SEC filing · Form 8-K | -0.49% | -0.80% | |
| Form 8-K CATALYST PHARMACEUTICALS For: May 21 | SEC filing · Form 8-K | -0.42% | -2.18% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -0.81% | +5.25% | |
| Form 8-K CATALYST PHARMACEUTICALS For: May 08 | SEC filing · Form 8-K | -0.81% | +5.25% | |
| Form ARS CATALYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | +0.20% | -0.82% | |
| Form DEF 14A CATALYST PHARMACEUTICALS For: May 21 | SEC filing · Form DEF | +0.20% | -0.82% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Mar 13 | SEC filing · Form 8-K | -0.65% | -4.88% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Feb 28 | SEC filing · Form 8-K | -1.90% | -1.66% | |
| Form 10-K CATALYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -1.90% | -1.66% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Feb 21 | SEC filing · Form 8-K | +0.36% | +1.46% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jan 09 | SEC filing · Form 8-K | -0.78% | -2.14% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jan 08 | SEC filing · Form 8-K | -0.51% | +2.86% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Jan 04 | SEC filing · Form 8-K | -0.51% | +2.86% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Dec 18 | SEC filing · Form 8-K | -0.75% | -2.65% | |
| Form S-8 CATALYST PHARMACEUTICALS | SEC filing · Form S-8 | -1.06% | -2.13% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Dec 01 | SEC filing · Form 8-K | +0.49% | -0.28% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -4.93% | -7.99% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Nov 08 | SEC filing · Form 8-K | -4.93% | -7.99% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Nov 02 | SEC filing · Form 8-K | -0.45% | -0.92% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Oct 26 | SEC filing · Form 8-K | +1.65% | +0.74% | |
| Form 8-K CATALYST PHARMACEUTICALS For: Oct 18 | SEC filing · Form 8-K | -1.01% | -1.65% |
Keep exploring
More CPRX: earnings → · analyst actions → · CPRX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Jaguar Health, Inc. (JAGX) | 442 | -0.38% | 41% |
| BOVIE MEDICAL (BVX) | 441 | 0.00% | 46% |
| Pacific Biosciences of California, Inc. (PACB) | 440 | -0.29% | 44% |
| EyePoint, Inc. (EYPT) | 439 | -0.25% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.